Vrije Universiteit Brussel

At Vrije Universiteit Brussel in Jette, clinical trials in neoplasms focus on blood cancers and related malignancies, including prostate cancer, multiple myeloma, and a range of hematological malignancies such as AML, MDS, CML, and lymphoma. The studies are designed to assess treatment effectiveness, compare therapeutic options, and monitor longer-term safety in patients who may continue to benefit from ongoing care.

• Evaluating new and existing treatments for prostate cancer and multiple myeloma
• Comparing approaches for relapsed/refractory multiple myeloma
• Supporting treatment decisions in hematological cancers with a focus on safety and benefit

These trials reflect a strong focus on improving outcomes for patients with complex cancers while helping clarify which therapies offer the most durable benefit.

Research in immune system diseases includes clinical trials for rheumatoid arthritis, where investigators are testing strategies to improve disease control and long-term patient outcomes. The work centers on reducing inflammation, improving remission rates, and understanding how treatment choices affect the course of disease over time.

• Studying treatment strategies for early rheumatoid arthritis
• Comparing approaches that aim to improve remission and reduce disease burden
• Following patients over time to assess safety and lasting effectiveness

This area highlights a practical effort to refine care for chronic inflammatory disease using evidence from both treatment and follow-up studies.

The site also conducts research in metabolism, with studies in type 1 diabetes mellitus aimed at preserving pancreatic beta-cell function and improving understanding of disease progression. These trials are intended to test whether a therapy can help maintain natural insulin production after diagnosis.

• Investigating ways to preserve beta-cell function in newly diagnosed type 1 diabetes
• Measuring changes in insulin-related responses over time
• Exploring treatments that may slow early disease progression

This research supports better care for people with diabetes by focusing on early intervention and disease preservation.

In the area of musculoskeletal diseases, trials at the Vrije Universiteit Brussel examine sarcopenia and related loss of mobility in older adults. The goal is to evaluate whether treatment can help maintain physical function and reduce the risk of disability.

• Studying therapies for sarcopenia in older patients
• Assessing ways to prevent or delay major mobility disability
• Focusing on quality of life and independence in aging populations

These studies address an important challenge in aging care by examining treatments that may support strength, movement, and daily functioning.

The hematology department also contributes to trials in allogeneic hematopoietic cell transplantation, comparing conditioning approaches for patients receiving donor transplants. This research is aimed at improving transplant success and long-term disease control while balancing safety and recovery.

• Comparing conditioning strategies for allogeneic stem cell transplantation
• Seeking better outcomes after transplant for blood cancers
• Evaluating treatment regimens that may improve survival and disease-free recovery

By studying transplant preparation and outcomes, the site supports advances in care for patients with serious blood disorders.